The Role of Adjuvant Chemotherapy in ypT0N0 Rectal Adenocarcinoma

Anita Nguyen, David R. James, Eric J. Dozois, Scott R. Kelley, Kellie L. Mathis

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Background: In patients who develop a complete pathologic response (ypT0N0) following neoadjuvant chemoradiation, the benefits of postoperative chemotherapy remain uncertain. This study aims to determine whether treatment with adjuvant chemotherapy in ypT0N0 patients affects short- and long-term outcomes. Methods: From January 2000 to December 2015, 992 patients at our institution underwent surgery for rectal adenocarcinoma following treatment with neoadjuvant chemoradiation. A complete pathologic response was noted in 96 (9.7%) patients. Adjuvant chemotherapy was administered to 60 (62.5%) patients. We reviewed clinical and pathological records and compared outcomes in ypT0N0 patients who received adjuvant chemotherapy to those who did not. Results: The mean age of patients who received adjuvant chemotherapy was 55.6 ± 11.5 years, compared to 62.1 ± 11.7 years for those who did not (p = 0.008). Among the two groups, mean follow-up time after surgery was 5.3 ± 4.1 years for the adjuvant group and 8.3 ± 5.5 years for the non-adjuvant cohort (p = 0.003). The 1, 3, and 5-year survival rates were 100.0%, 97.7%, and 92.1% for patients who received adjuvant chemotherapy and 97.2%, 94.1%, and 90.7% for those who did not (p = 0.382). In a subanalysis of patients with available follow-up information, we observed 3/53 (5.7%) disease recurrences in patients who received adjuvant chemotherapy, compared to 2/18 (11.1%) in those who were not treated postoperatively (p = 0.456). Conclusion: In patients with ypT0N0 rectal adenocarcinoma, we found equivalent survival and recurrence outcomes. Further study will be necessary to determine the importance of adjuvant chemotherapy following ypT0N0 resection.

Original languageEnglish (US)
Pages (from-to)2263-2268
Number of pages6
JournalJournal of Gastrointestinal Surgery
Issue number11
StatePublished - Nov 1 2019


  • Pathologic complete response
  • Rectal adenocarcinoma

ASJC Scopus subject areas

  • Surgery
  • Gastroenterology


Dive into the research topics of 'The Role of Adjuvant Chemotherapy in ypT0N0 Rectal Adenocarcinoma'. Together they form a unique fingerprint.

Cite this